CVS Caremark Corporation (NYSE:CVS)’s EVP sells 53,546 shares
Executive Vice-President of CVS Caremark Corp. (NYSE:CVS), Helena Foulkes sold-off 53,546 shares of the company’s stock in the open-market in a transaction that took place on 13 September. The stock was sold-off at an average-price of $60.00 and the total valuation of the transaction was $3,212,760.00. Post completion of the sale, the EVP now directly-owns 7,897 shares in CVS Caremark Corporation (NYSE:CVS). This sale was disclosed in a SEC filing
Recently, the company has been weighed by numerous research analysts. Cowen and Company analysts set a “market perform” rating on the stock on Friday. Zacks analysts reiterated their “neutral” rating on the company shares on 28 August and have now assigned a $61.00 price-target on the stock. Barclays Capital analysts have raised their price target on the shares from $67.00 to $69.00 on 8 August.
Six research analysts have assigned a “hold” rating on the stock and 20 analysts have assigned a “buy” rating. The average rating on the CVS Caremark Corporation (NYSE:CVS) stock is a “buy” and the average price-target is $62.89.
The company last issued its quarterly-earnings report on 6 August. It reported earnings per share of $0.97 for the quarter which topped the analyst estimate of $0.96 by $0.01. The revenue for the quarter came in at $31.25 billion in comparison to the average analyst estimate of $31.13B. In the same quarter of 2012, the company had posted earnings per share of $0.8. There was a 1.7% rise in revenue in comparison to the same quarter of 2012. On an average, analysts project that CVS Caremark Corporation (NYSE:CVS) will post earnings per share of $3.96 for the 2013 fiscal year.
In Monday’s trading, CVS Caremark Corporation (NYSE:CVS) stock rose by 1.75%. The shares opened at a price of $60.39 which climbed to an intraday high of $61.17 and then dipped to close at $60.95